In this work, we have shown that hepatitis C virus (HCV) and hepatitis B virus (HBV) can coexist in the same hepatocyte using double fluorescent in situ hybridization in liver biopsy samples from patients with chronic HCV infection with occult HBV infection. Digital image analysis of ...
There are over 350 million chronic HBV carriers, nearly 71 million people infected with HCV and 20 million people infected with HEV worldwide1. Persistent damage to the liver may trigger liver cirrhosis (LC), i.e., a stage of partial loss of liver structure and function and potentially life...
有研究对82名HBsAg阴性且HCV阴性的肝硬化患者进行随访,随访5年时HBV DNA 阳性和阴性患者的肿瘤发生率分别为27%和11.8%;随访至10 年时,HBV阳性组全部发生肝癌,HBV 阴性组肿瘤的发生率为27%。 OBI诱导肝癌发生可能涉及几种机制,当HBV DNA整合到宿主基因组中时,整...
A mild ALT (mean 113,44 ± 61,35 U/dL) derangement was found during treatment in 47 patients (9,44%) without evidence of any liver infection and this was attributed to an effect of chemotherapy. No OBI reactivations were diagnosed in HBsAb positive, in HCVAb positive and totally negative...
[5,20]. However, more recent studies have brought into question the interplay between HCV and HBV, and when the in vitro cotransfection experiments were conducted with full-length HBV genomes and HCV replicon (thus, not limiting the study to a single HCV protein), no interference between the...
457 HCV and HBV can coinfect the same hepatocyte in the liver of patients with chronic hepatitis C and occult HBV infectiondoi:10.1016/S0168-8278(05)81869-0SDOSJournal of Hepatology
HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection. Sci Rep 2016;6:39409.Chen F, Zhang J, Wen B, Luo S, Lin Y, Ou W, et al HBV/HCV dual infection impacts viral load, antibody response, and cytokine ...
Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years
The effect of the short course of the recombinant interleukin-2 in patients with liver cirrhosis causes by HBV and HCV infectionIlyassova B.S
122Early steatosis and past HBV infection predict fibrosis progression in liver transplant recipients with recurrent HCV infectiondoi:10.1016/S1527-6465(05)80150-9TISONE, GANGELICO, MPALMIERI, GDIPAOLO, DTORRI, EIARIA, GBAIOCCHI, LANSELMO, A...